| 4 | 1/1 | 返回列表 |
| 查看: 692 | 回復(fù): 3 | ||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進行查看 | ||
cainiaodui新蟲 (小有名氣)
|
[求助]
求助翻譯
|
|
|
Given these findings, coupling agents that block the VEGF pathway with agents targeting the Notch pathway may result in enhanced treatment efficacy. Combined therapy may therefore overcome the issue of tumor escape that is associated with single-agent treatments. Evidence of this benefit was demonstrated when anti-DLL4 antibody was combined with VEGF inhibition in human lung carcinoma and mouse leukemia tumor models. In both studies, combined therapy resulted in enhanced tumor growth inhibition as compared to either monotherapy.It has also been shown that human sarcoma xenograft tumors in mice that are unresponsive to VEGF inhibition are instead responsive to DLL4 blocking antibody.These data further exemplify the crosstalk between VEGF and the Notch signaling pathway. Clearly, the field of Notch pathway inhibitors is a new and exciting area in cancer research, and additional study of their use both alone and in combination with chemotherapy or other biological agents should be explored. |
鐵桿木蟲 (著名寫手)
版主 (文壇精英)

版主 (文壇精英)
| 考慮到這些研究結(jié)果,偶聯(lián)劑阻斷VEGF通路同時用靶向試劑靶向Notch通路可以增強治療效果。聯(lián)合治療因此可克服與單一藥物治療有關(guān)的腫瘤逃逸問題。 在人肺癌和白血病小鼠腫瘤模型抗DLL4抗體聯(lián)合VEGF抑制顯示了如此的治療效果。這兩項研究中,聯(lián)合治療腫瘤生長抑制作用與但種藥物治療相比,抑制作用增強。而且,還已經(jīng)表明,人類肉瘤異種移植到小鼠的腫瘤對血管內(nèi)皮生長因子抑制無反應(yīng)性,但對DLL4封閉抗體有反應(yīng)。這些數(shù)據(jù)進一步說明VEGF信號通路和Notch信號信號通路之間的串?dāng)_/相互作用。顯然, Notch通路抑制劑是癌癥研究中一個全新的和令人激動的領(lǐng)域,應(yīng)用兩種方法單獨或兩種方法與化療或其他生物試劑聯(lián)合使用應(yīng)該進行進一步探討、研究。 |

| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 303求調(diào)劑 +6 | 藍山月 2026-03-25 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 308求調(diào)劑 +5 | 墨墨漠 2026-03-25 | 5/250 |
|
|
[考研] 309求調(diào)劑 +3 | gajsj 2026-03-25 | 4/200 |
|
|
[考研] 299求調(diào)劑 +3 | 15188958825 2026-03-25 | 3/150 |
|
|
[考研] 化學(xué)調(diào)劑一志愿上海交通大學(xué)336分-本科上海211 +3 | 小魚愛有機 2026-03-25 | 3/150 |
|
|
[考研] 333求調(diào)劑 +6 | 87639 2026-03-21 | 11/550 |
|
|
[考研] 347求調(diào)劑 +4 | L when 2026-03-25 | 4/200 |
|
|
[考研] 0854電子信息求調(diào)劑 324 +4 | Promise-jyl 2026-03-23 | 4/200 |
|
|
[考研] 一志愿吉林大學(xué)材料與化工303分求調(diào)劑 +4 | 為學(xué)666 2026-03-24 | 4/200 |
|
|
[考研] 一志愿 西北大學(xué) ,070300化學(xué)學(xué)碩,總分287,雙非一本,求調(diào)劑。 +4 | 晨昏線與星海 2026-03-20 | 4/200 |
|
|
[考研] 318求調(diào)劑 +5 | plum李子 2026-03-21 | 8/400 |
|
|
[考博] 申博26年 +4 | 八6八68 2026-03-19 | 4/200 |
|
|
[考研] 【雙一流院校新能源、環(huán)境材料,材料加工與模擬招收大量調(diào)劑】 +4 | Higraduate 2026-03-22 | 7/350 |
|
|
[考研] 336求調(diào)劑 +4 | 收到VS 2026-03-20 | 4/200 |
|
|
[考研] 求老師收我 +3 | zzh16938784 2026-03-23 | 3/150 |
|
|
[考研] 材料與化工085600,總分304,本科有兩篇sci參與,求調(diào)劑 +4 | 幸運的醬醬 2026-03-22 | 5/250 |
|
|
[考研] 求調(diào)劑一志愿海大,0703化學(xué)學(xué)碩304分,有大創(chuàng)項目,四級已過 +6 | 幸運哩哩 2026-03-22 | 10/500 |
|
|
[考研] 279求調(diào)劑 +5 | 紅衣隱官 2026-03-21 | 5/250 |
|
|
[考研] 22408 344分 求調(diào)劑 一志愿 華電計算機技術(shù) +4 | solanXXX 2026-03-20 | 4/200 |
|
|
[考研] 中南大學(xué)化學(xué)學(xué)碩337求調(diào)劑 +3 | niko- 2026-03-19 | 6/300 |
|